Occupational and Environmental Lung Disease

The answer first

Occupational and environmental lung disease is a heterogeneous group of conditions in which inhaled dusts, fibres, fumes, allergens, or gases cause a predictable pattern of parenchymal, airway, or pleural disease in a worker or community member with a defined exposure. ^[1] The answer-first physician approach is to (1) take a meticulous lifetime occupational and environmental exposure history, (2) recognise the radiographic and physiological pattern that the exposure produces, (3) confirm the diagnosis with the appropriate imaging, physiology, and — for beryllium and HP — immunological or bronchoalveolar-lavage testing, and (4) deliver a sequenced plan that always begins with exposure elimination or reduction, supplemented by disease-specific therapy and surveillance for the complications (especially lung cancer and mesothelioma) that drive long-term mortality. ^{[1] [4]}

For the FRACP candidate, occupational lung disease is a high-yield long case because it demands integration of the exposure history (often unrecognised by the patient), the radiographic pattern (upper-lobe nodules in silicosis and coal workers' pneumoconiosis, lower-lobe fibrosis in asbestosis, mosaic attenuation in HP), and the legal and compensation dimensions of an occupational disease. The opening sentence must name the dominant phenotype ("a 55-year-old former stonemason with engineered-stone silicosis, progressive massive fibrosis, and biopsy-proven Mycobacterium abscessus overlap") and the problem list must order threats first: exposure cessation, surveillance for tuberculosis and lung cancer, antifibrotic therapy where progressive fibrosis is documented, and the social and compensation framework that determines ongoing care. ^{[2] [3]}

References14ShowHide

1. [1]Hua JT, Cool CD, Green FHY Pathology and Mineralogy of the Pneumoconioses Semin Respir Crit Care Med, 2023.PMID 36972614
2. [2]Leung CC, Yu IT, Chen W Silicosis Lancet, 2012.PMID 22534002
3. [3]Leso V, Fontana L, Romano R, et al. Artificial Stone Associated Silicosis: A Systematic Review Int J Environ Res Public Health, 2019.PMID 30781462
4. [4]Caceres JD, Venkata AN Asbestos-associated pulmonary disease Curr Opin Pulm Med, 2023.PMID 36630203
5. [5]Ross RM The clinical diagnosis of asbestosis in this century requires more than a chest radiograph Chest, 2003.PMID 12970045
6. [6]Hall NB, Blackley DJ, Halldin CN, et al. Current Review of Pneumoconiosis Among US Coal Miners Curr Environ Health Rep, 2019.PMID 31302880
7. [7]Blackley DJ, Halldin CN, Laney AS Progressive Massive Fibrosis in Coal Miners From 3 Clinics in Virginia JAMA, 2018.PMID 29411024
8. [8]Fernández Pérez ER, Travis WD, Lynch DA, et al. Diagnosis and Evaluation of Hypersensitivity Pneumonitis: CHEST Guideline and Expert Panel Report Chest, 2021.PMID 33861992
9. [9]Raghu G, Collard HR, Egan JJ, et al. An official ATS/ERS/JRS/ALAT statement: idiopathic pulmonary fibrosis: evidence-based guidelines for diagnosis and management Am J Respir Crit Care Med, 2011.PMID 21471066
10. [10]Raghu G, Remy-Jardin M, Richeldi L, et al. Idiopathic Pulmonary Fibrosis (an Update) and Progressive Pulmonary Fibrosis in Adults: An Official ATS/ERS/JRS/ALAT Clinical Practice Guideline Am J Respir Crit Care Med, 2022.PMID 35486072
11. [11]Baur X, Aasen TB, Burge PS, et al. Guidelines for the management of work-related asthma Eur Respir J, 2012.PMID 22379148
12. [12]Newman LS, Mroz MM, Balkissoon R, Maier LA Efficacy of serial medical surveillance for chronic beryllium disease in a beryllium machining plant J Occup Environ Med, 2001.PMID 11285871
13. [13]Adams TN, Butt YM, Batra K, et al. Cobalt related interstitial lung disease Respir Med, 2017.PMID 28732841
14. [14]O'Reilly KM, Mclaughlin AM, Beckett WS, et al. Asbestos-related lung disease Am Fam Physician, 2007.PMID 17375514